CDC Online NewsroomUnited States28 November 2016
CDC Telebriefing: New Vital Signs Report How can expanded syringe services programs protect gains in HIV prevention? - Media Advisory
This is an official announcement record
Firsthand records what CDC Online Newsroom announced and links to the original. The wording below is theirs, not ours.
One consequence of the nation's devastating opioid epidemic is the increased risk of HIV and hepatitis B and C transmission through unsafe injection drug use. Syringe services programs (SSPs) can greatly reduce that risk.
Read the official announcement
Opens tools.cdc.gov
More from CDC Online Newsroom
- Annual Report to the Nation: Progress Against Lung Cancer Drives Down Cancer Mortality22 September 2026
- CDC Data Show Encouraging Progress in Youth Health21 September 2026
- CDC Statement on Increases in Recent Animal Rabies Activity and Associated Human Exposures10 September 2026
- Twenty-Five Years After 9/11 - Lessons from the World Trade Center Health Program10 September 2026
- CDC Launches New Overdose Prevention Data Channel31 August 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program — especially if you are pregnant, nursing, taking medication, or managing a health condition.